WIC
GSK icon

Woodmont Investment Counsel’s GSK GSK Stock Holding History

Woodmont Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-480
Closed -$26K – 361
2016
Q3 		$26K Buy
+480
New +$26.3K 0.01% 329
2016
Q2 		– Sell
-667
Closed -$34K – 296
2016
Q1 		$34K Hold
667
– – 0.01% 300
2015
Q4 		$34K Hold
667
– – 0.01% 304
2015
Q3 		$32K Buy
667
+187
+39% +$9.73K 0.01% 304
2015
Q2 		$25K Buy
+480
New +$27K 0.01% 332

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodmont Investment Counsel's GSK Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of GSK (GSK) in Q4 2016, closing a stake of 480 shares — an estimated $26K sold.

Woodmont Investment Counsel first reported a position in GSK in Q2 2015 and held it in 5 quarters. The position peaked at $34K in Q1 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 480 GSK shares in Q4 2016, an estimated $26K.
  • Woodmont Investment Counsel first reported a position in GSK in Q2 2015 and held it in 5 quarters.
  • Woodmont Investment Counsel's GSK position peaked at $34K in Q1 2016.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.